Insider Trading Alert - CYH, WNR And SAM Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, March 5, 2014, 233 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $57.59 to $85,937,500.00.

Highlighted Stocks Traded by Insiders:

Community Health Systems (CYH) - FREE Research Report

Fry John A who is Director at Community Health Systems sold 10,000 shares at $41.43 on March 5, 2014. Following this transaction, the Director owned 22,301 shares meaning that the stake was reduced by 30.96% with the 10,000-share transaction.

The shares most recently traded at $41.16, down $0.27, or 0.66% since the insider transaction. Historical insider transactions for Community Health Systems go as follows:

  • 4-Week # shares sold: 3,154
  • 12-Week # shares sold: 3,154
  • 24-Week # shares sold: 3,154

The average volume for Community Health Systems has been 1.7 million shares per day over the past 30 days. Community Health Systems has a market cap of $4.8 billion and is part of the health care sector and health services industry. Shares are up 6.72% year-to-date as of the close of trading on Wednesday.

Community Health Systems, Inc., together with its subsidiaries, provides general and specialized hospital healthcare services to patients in the United States. The company has a P/E ratio of 27.8. Currently there are 11 analysts that rate Community Health Systems a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CYH - FREE

TheStreet Quant Ratings rates Community Health Systems as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Community Health Systems Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Western Refining (WNR) - FREE Research Report

Foster Paul L who is Chairman of BOD, Exec. Chair at Western Refining sold 100,000 shares at $35.99 on March 5, 2014. Following this transaction, the Chairman of BOD, Exec. Chair owned 20.1 million shares meaning that the stake was reduced by 0.49% with the 100,000-share transaction.

The shares most recently traded at $38.89, up $2.90, or 7.45% since the insider transaction. Historical insider transactions for Western Refining go as follows:

  • 4-Week # shares sold: 50,000
  • 12-Week # shares sold: 60,000
  • 24-Week # shares sold: 971,617

The average volume for Western Refining has been 1.5 million shares per day over the past 30 days. Western Refining has a market cap of $2.9 billion and is part of the basic materials sector and energy industry. Shares are down 13.44% year-to-date as of the close of trading on Wednesday.

Western Refining, Inc. operates as an independent crude oil refiner and marketer of refined products. It operates in three segments: Refining, Wholesale, and Retail. The stock currently has a dividend yield of 2.4%. The company has a P/E ratio of 13.2. Currently there are 4 analysts that rate Western Refining a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WNR - FREE

TheStreet Quant Ratings rates Western Refining as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Western Refining Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Boston Beer Company (SAM) - FREE Research Report

Koch C James who is Chairman at Boston Beer Company sold 1,000 shares at $240.05 on March 5, 2014. Following this transaction, the Chairman owned 25,534 shares meaning that the stake was reduced by 3.77% with the 1,000-share transaction.

The shares most recently traded at $245.87, up $5.82, or 2.37% since the insider transaction. Historical insider transactions for Boston Beer Company go as follows:

  • 4-Week # shares sold: 21,118
  • 12-Week # shares sold: 32,319
  • 24-Week # shares sold: 43,010

The average volume for Boston Beer Company has been 76,000 shares per day over the past 30 days. Boston Beer Company has a market cap of $2.2 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 0.72% year-to-date as of the close of trading on Wednesday.

The Boston Beer Company, Inc. engages in the production and sale of alcohol beverages primarily in the United States, Canada, Europe, Israel, the Caribbean, the Pacific Rim, and Mexico. The company has a P/E ratio of 47.0. Currently there is 1 analyst that rates Boston Beer Company a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on SAM - FREE

TheStreet Quant Ratings rates Boston Beer Company as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in net income, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Boston Beer Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

AMD Rises Above the Competition; Loan Losses Mount for Big Banks -- ICYMI

AMD Rises Above the Competition; Loan Losses Mount for Big Banks -- ICYMI

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Why Nashville, Denver, LA Should Reconsider Bids for Amazon HQ2

Why Nashville, Denver, LA Should Reconsider Bids for Amazon HQ2